Analysis of DAX1 (NR0B1) and Steroidogenic Factor-1 (NR5A1) in Children and Adults with Primary Adrenal Failure: Ten Years Experience
Lin Lin,
Wen-Xia Gu,
Gokhan Ozisik,
Wing S. To,
Catherine J. Owen,
J. Larry Jameson and
John C. Achermann
UCL Institute of Child Health and Department of Medicine (L.L., W.S.T., J.C.A.), University College London, London WC1N 1EH, United Kingdom; Department of Medicine (W.-X.G., J.L.J.), Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois 60611; Division of Endocrinology and Metabolism (G.O.), Gulhane Askeri Tip Akademisi Medical School, Haydarpasa Hospital, Istanbul 34670, Turkey; and Institute of Human Genetics (C.J.O.), School of Clinical Medical Sciences, University of Newcastle, Newcastle upon Tyne NE1 3BZ, United Kingdom
Address all correspondence and requests for reprints to: Dr. John C. Achermann, Biochemistry, Endocrinology & Metabolism, University College London Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom. E-mail: j.achermann{at}ich.ucl.ac.uk.
Context: Primary adrenal failure is a life-threatening conditionthat can be caused by a range of etiologies, including autoimmune,metabolic, and developmental disorders. The nuclear receptorsDAX1 (NR0B1) and steroidogenic factor-1 (SF1/Ad4BP, NR5A1) playan important role in adrenal development and function, and mutationsin these transcription factors have been found in patients withadrenal hypoplasia.
Objective: Our objective was to investigate the prevalence ofDAX1 and SF1 mutations in children and adults with primary adrenalfailure of unknown etiology (i.e. not caused by congenital adrenalhyperplasia, adrenoleukodystrophy, or autoimmune disease).
Patients: One hundred seventeen patients were included. Eighty-eightindividuals presented in infancy or childhood with adrenal hypoplasiaor primary adrenal failure of unknown etiology (n = 64 46,XYphenotypic males; n = 17 46,XY gonadal dysgenesis/impaired androgenization;n = 7 46,XX females). Twenty-nine individuals presented in adulthoodwith Addisons disease of unknown etiology.
Methods: Mutational analysis of DAX1 (NR0B1) (including exon2/1A) and SF1 (NR5A1) was done by direct sequencing.
Results: DAX1 mutations were found in 58% (37 of 64) of 46,XYphenotypic boys referred with adrenal hypoplasia and in allboys (eight of eight) with hypogonadotropic hypogonadism anda family history suggestive of adrenal failure in males. SF1mutations causing adrenal failure were found in only two patientswith 46,XY gonadal dysgenesis. No DAX1 or SF1 mutations wereidentified in the adult-onset group.
Conclusions: DAX1 mutations are a relatively frequent causeof adrenal failure in this group of boys. SF1 mutations causingadrenal failure in humans are rare and are more likely to beassociated with significant underandrogenization and gonadaldysfunction in 46,XY individuals.
This article has been cited by other articles:
L. A. Metherell, D. Naville, G. Halaby, M. Begeot, A. Huebner, G. Nurnberg, P. Nurnberg, J. Green, J. W. Tomlinson, N. P. Krone, et al. Nonclassic Lipoid Congenital Adrenal Hyperplasia Masquerading as Familial Glucocorticoid Deficiency
J. Clin. Endocrinol. Metab.,
October 1, 2009;
94(10):
3865 - 3871.
[Abstract][Full Text][PDF]
B. Skinningsrud, E. S. Husebye, G. D. Gilfillan, E. Frengen, A. Erichsen, K. Gervin, E. Ormerod, T. Egeland, and D. E. Undlien X-Linked Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism Caused by an Inversion Disrupting a Conserved Noncoding Element Upstream of the NR0B1 (DAX1) Gene
J. Clin. Endocrinol. Metab.,
October 1, 2009;
94(10):
4086 - 4093.
[Abstract][Full Text][PDF]
A. C. Kim, F. M. Barlaskar, J. H. Heaton, T. Else, V. R. Kelly, K. T. Krill, J. O. Scheys, D. P. Simon, A. Trovato, W.-H. Yang, et al. In Search of Adrenocortical Stem and Progenitor Cells
Endocr. Rev.,
May 1, 2009;
30(3):
241 - 263.
[Abstract][Full Text][PDF]
B. Ferraz-de-Souza, F. Martin, D. Mallet, R. E. Hudson-Davies, P. Cogram, L. Lin, D. Gerrelli, F. Beuschlein, Y. Morel, A. Huebner, et al. CBP/p300-Interacting Transactivator, with Glu/Asp-Rich C-Terminal Domain, 2, and Pre-B-Cell Leukemia Transcription Factor 1 in Human Adrenal Development and Disease
J. Clin. Endocrinol. Metab.,
February 1, 2009;
94(2):
678 - 683.
[Abstract][Full Text][PDF]
E. P. Sablin, A. Woods, I. N. Krylova, P. Hwang, H. A. Ingraham, and R. J. Fletterick The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1
PNAS,
November 25, 2008;
105(47):
18390 - 18395.
[Abstract][Full Text][PDF]
M G Shaikh, L Boyes, H Kingston, R Collins, G T N Besley, B Padmakumar, O Ismayl, I Hughes, C M Hall, C Hellerud, et al. Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita
J. Med. Genet.,
September 1, 2008;
45(9):
e1 - e1.
[Abstract][Full Text][PDF]
C. J. Kim, L. Lin, N. Huang, C. A. Quigley, T. W. AvRuskin, J. C. Achermann, and W. L. Miller Severe Combined Adrenal and Gonadal Deficiency Caused by Novel Mutations in the Cholesterol Side Chain Cleavage Enzyme, P450scc
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
696 - 702.
[Abstract][Full Text][PDF]
G. J. Bouma, L. L. Washburn, K. H. Albrecht, and E. M. Eicher Correct dosage of Fog2 and Gata4 transcription factors is critical for fetal testis development in mice
PNAS,
September 18, 2007;
104(38):
14994 - 14999.
[Abstract][Full Text][PDF]
C Russo, E J Davis, P R Betts, and J H Davies The importance of re-evaluation, re-investigation and follow-up of adrenal insufficiency
Arch. Dis. Child. Ed. Pract.,
August 1, 2007;
92(4):
ep109 - ep113.
[Full Text][PDF]
A. A. Verrijn Stuart, G. Ozisik, M. A. de Vroede, J. C. Giltay, R. J. Sinke, T. J. Peterson, R. M. Harris, J. Weiss, and J. L. Jameson An Amino-Terminal DAX1 (NROB1) Missense Mutation Associated with Isolated Mineralocorticoid Deficiency
J. Clin. Endocrinol. Metab.,
March 1, 2007;
92(3):
755 - 761.
[Abstract][Full Text][PDF]
L. Lin, P. Philibert, B. Ferraz-de-Souza, D. Kelberman, T. Homfray, A. Albanese, V. Molini, N. J. Sebire, S. Einaudi, G. S. Conway, et al. Heterozygous Missense Mutations in Steroidogenic Factor 1 (SF1/Ad4BP, NR5A1) Are Associated with 46,XY Disorders of Sex Development with Normal Adrenal Function
J. Clin. Endocrinol. Metab.,
March 1, 2007;
92(3):
991 - 999.
[Abstract][Full Text][PDF]